The short version of deamidation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-15. Anything still debated is marked as such rather than presented as settled.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
==== Combustion ==== The combustion of all carbon-based fuels, such as methane (natural gas), petroleum distillates (gasoline, diesel, kerosene, propane), coal, wood and generic organic matter produces carbon dioxide and, except in the case of pure carbon, water. As an example, the chemical reaction between methane and oxygen:
Any drug (including a biological product for human use), medical device for human use, human food additive, color additive, electronic product, or any other article subject to regulation under the FD&C Act (21CFR50.3) Toxicity
=== Wisezah Buckman === Wisezah Datawn Buckman (born November 12, 1987) was a resident of Elizabeth City, North Carolina. Although details of his life before the murders were sparse, Buckman was said to have come from a dysfunctional family background, which purportedly caused him to suffer from cognitive impairments in later life. Buckman was also married with three young children prior to his incarceration. The 2017 prison murders were not the first time Buckman had committed murder. Three years prior, in 2014, Buckman was charged with first degree murder for the fatal shooting of 36-year-old Thurmont Deant Davis, for which he originally faced a maximum sentence of life without parole. Due to a plea agreement in 2015, Buckman was convicted of a lesser charge of second degree murder and sentenced to a prison term of 26 to 32 years in the Pasquotank Correctional Institution.
Bioassessment A decline in a macrophyte community may indicate water quality problems and changes in the ecological status of the water body. Such problems may be the result of excessive turbidity, herbicides, or salination. Conversely, overly high nutrient levels may create an overabundance of macrophytes, which may in turn interfere with lake processing. Macrophyte levels are easy to sample, do not require laboratory analysis, and are easily used for calculating simple abundance metrics.
== Structure == STAT5a shares the same six functional domains as the other members of the STAT family. It contains 20 amino acids unique to its C-terminal domain and is 96% similar to its homolog, STAT5b. The six functional domains and their corresponding amino acid positions are as follows:
Sources: en.wikipedia.org
1993/453) National Rivers Authority (Anglian Region) (Reconstitution of the North Level Internal Drainage Board) Order 1992 S.I. 1993/454) Environmentally Sensitive Areas (Breckland) Designation Order 1993 (S.I. 1993/455) Environmentally Sensitive Areas (Clun) Designation Order 1993 (S.I. 1993/456) Environmentally Sensitive Areas (North Peak) Designation Order 1993 (S.I. 1993/457) Environmentally Sensitive Areas (Suffolk River Valleys) Designation Order 1993 (S.I. 1993/458) Environmentally Sensitive Areas (Test Valley) Designation Order 1993 (S.I. 1993/459) Environmentally Sensitive Areas (Pennine Dales) Designation (Amendment) Order 1993 (S.I. 1993/460) National Assistance (Sums for Personal Requirements) Regulations 1993 (S.I. 1993/462) Education (Further Education Corporations) (Designated Staff) Order 1993 (S.I. 1993/465) Bradford, Kirklees and Leeds (City and Metropolitan Borough Boundaries) Order 1993 (S.I. 1993/473) Warwickshire and West Midlands (County and District Boundaries) Order 1993 (S.I. 1993/474) Merchant Shipping (Light Dues) (Amendment) Regulations 1993 (S.I. 1993/475) Wireless Telegraphy (Television Licence Fees) (Amendment) Regulations 1993 (S.I. 1993/476) Residential Accommodation (Relevant Premises, Ordinary Residence and Exemptions) Regulations 1993 (S.I. 1993/477) Social Security (Claims and Payments) Amendment Regulations 1993 (S.I. 1993/478) Social Fund Maternity and Funeral Expenses (General) Amendment Regulations 1993 (S.I. 1993/479) Personal Injuries (Civilians) Amendment Scheme 1993 (S.I.
==== Identification of the formula ==== In the early 1700s, Georg Ernst Stahl claimed that reacting sulfuric acid with limestone produced a sort of alum. The error was soon corrected by Johann Pott and Andreas Marggraf, who showed that the precipitate obtained when an alkali is poured into a solution of alum, namely alumina, is quite different from lime and chalk, and is one of the ingredients in common clay. Marggraf also showed that perfect crystals with properties of alum can be obtained by dissolving alumina in sulfuric acid and adding potash or ammonia to the concentrated solution. In 1767, Torbern Bergman observed the need for potassium or ammonium sulfates to convert aluminium sulfate into alum, while sodium or calcium would not work. At the time, potassium ("potash") was believed to be exclusively found on plants. However, in 1797, Martin Klaproth discovered the presence of potassium in the minerals leucite and lepidolite. Louis Vauquelin then conjectured that potassium was likewise an ingredient in many other minerals. Given Marggraf and Bergman's experiments, he suspected that this alkali constituted an essential ingredient of natural alum. In 1797 he published a dissertation demonstrating that alum is a double salt, composed of sulfuric acid, alumina, and potash. In the same journal volume, Jean-Antoine Chaptal published the analysis of four different kinds of alum, namely, Roman alum, Levant alum, British alum and alum manufactured by himself, confirming Vauquelin's results.
=== Mechanical properties === α-Helices under axial tensile deformation, a characteristic loading condition that appears in many alpha-helix-rich filaments and tissues, results in a characteristic three-phase behavior of stiff-soft-stiff tangent modulus. Phase I corresponds to the small-deformation regime during which the helix is stretched homogeneously, followed by phase II, in which alpha-helical turns break mediated by the rupture of groups of H-bonds. Phase III is typically associated with large-deformation covalent bond stretching.
== Other projects == Staley shared lead vocals with Ann Wilson for a cover of Bob Dylan's "Ring Them Bells", featured on Heart's 1993 album Desire Walks On. The song "It's Coming After" from Second Coming's 1994 debut album L.O.V.Evil features Staley on lead vocals. Second Coming features Staley's bandmates from Alice N' Chains, his former band. One of the last songs that Staley recorded was a cover of Pink Floyd's "Another Brick in the Wall" with the supergroup Class of '99, featuring guitarist Tom Morello of Rage Against the Machine, bassist Martyn LeNoble, drummer Stephen Perkins, both from Jane's Addiction and Porno for Pyros, and keyboardist Matt Serletic. In November 1998, the group recorded the song for Robert Rodriguez's 1998 horror/sci-fi film The Faculty. A music video was also released. While the other members of the band were filmed specifically for the video, Staley's appearance consisted of footage pulled from Mad Season's 1995 Live at the Moore video. A song titled "Things You Do" featuring Staley on vocals was part of the soundtrack to the 2012 film Grassroots. In the film, the song was credited to "The Bondage Boys featuring Layne Staley", but the song had been credited to "Layne Staley and The Aftervibes" and "Layne Staley and Second Coming" when it leaked on the internet years before.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.